Skip to main content
2024 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Sarika Namjoshi, PhD

Head of Formulation and Analytical
Vaxxas Pty Ltd
HAMILTON, Queensland, Australia

Dr Namjoshi has worked in the pharmaceutical industry since 2009 in formulation development, manufacture, characterization, and registration of new dermatology products. She has extensive experience in development of novel active skin delivery platforms and assessment of skin permeation of several actives using formulation approaches, chemical and physical conjugation to enhance delivery. Dr Namjoshi was a Principal investigator on FDA projects developing a tool kit for in vitro characterization of bioequivalence of topical products.
She has more than 15 years’ experience in pharmaceutical product development (CMC) of several dosage forms with a broad knowledge base in pharmaceutical sciences, biotechnology, medical devices, and deep understanding of industry practices. Over her career, she has held multiple leadership positions in pharmaceutical industries across Australia. At Vaxxas she is the Head of Formulation & Analytical, responsible for formulation and process development, analytical method development and validation.

Disclosure information not submitted.

Presentation(s):